# Specification Quality Checklist: Proportionate Effort

**Purpose**: Validate specification completeness and quality before proceeding to planning
**Created**: 2026-10-02
**Feature**: [spec.md](../spec.md)

## Content Quality

- [x] No implementation details (languages, frameworks, APIs)
- [x] Focused on user value and business needs
- [x] Written for non-technical stakeholders
- [x] All mandatory sections completed

## Requirement Completeness

- [x] No [NEEDS CLARIFICATION] markers remain
- [x] Requirements are testable and unambiguous
- [x] Success criteria are measurable
- [x] Success criteria are technology-agnostic (no implementation details)
- [x] All acceptance scenarios are defined
- [x] Edge cases are identified
- [x] Scope is clearly bounded
- [x] Dependencies and assumptions identified

## Feature Readiness

- [x] All functional requirements have clear acceptance criteria
- [x] User scenarios cover primary flows
- [x] Feature meets measurable outcomes defined in Success Criteria
- [x] No implementation details leak into specification

## Notes

- As in 002, the product is a developer workflow tool, so its vocabulary (stage, gate, approval, `[ai-draft]`, `ai-decided`, `show`, `accept`, the active-story pointer, the record file) names user-facing concepts, not implementation choices. The helper is named where Constitution Principle I requires it (FR-046) and where a rule must be deterministic (FR-028, FR-032).
- Three behaviour-level clarifications resolved on 2026-10-02 (recorded under Clarifications): FR-006 refuse a start on another story's branch until confirmed; FR-021 the profile asks two comprehension levels; FR-032 own decisions recorded as `own-decision`.
- Amendments to earlier specs are named in Assumptions: 002 FR-010, 002 FR-047 and 002's records-inside-documents assumption. The `ai-decided` rule narrows the Technical prompt's "a technical decision is the developer's"; whether the constitution needs a PATCH clarification is left to `/speckit-analyze`.
- The SC-010 data point (FR-041) was recorded in `docs/trials.md` on 2026-10-02.
